| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $167.9M | $267.4M | $411.8M |
| YoY Revenue Growth % | -37.2% | -35.1% | — |
| Gross Profit | $35.3M | $66.2M | — |
| Gross Margin % | 21.0% | 24.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$50.1M | -$38.0M | -$46.0M |
| Operating Margin % | -29.8% | -14.2% | -11.2% |
| Net Income (GAAP) | -$54.1M | -$95.7M | -$39.4M |
| EBITDA (Normalized) | -$50.0M | -$37.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$45.5M | $786.0K | -$2.4M |
| Capital Expenditures (CapEx) | $94.0K | $1.3M | — |
| Free Cash Flow (FCF) | -$45.6M | -$497.0K | -$2.4M |
| FCF Margin % | -27.2% | -0.2% | -0.6% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $18.5M | $75.3M | — |
| Total Debt (Short + Long Term) | $61.1M | $58.1M | — |
| Total Stockholders' Equity | -$17.5M | $28.4M | — |